Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bionano Genomics Inc BNGO

Technology Scientific & Technical Instruments
Bionano Genomics, Inc. is a genomics company. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. Through Lineagen, Inc., the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. It also offers a platform... see more

Recent & Breaking News (NDAQ:BNGO)

Bionano to Present at the 43rd Annual Cowen Healthcare Conference

GlobeNewswire February 27, 2023

Bionano Announces China NMPA Approval for DNA Extraction and Labeling Products for IVD Use in Hematologic Malignancies

GlobeNewswire February 22, 2023

Bionano Shares Overview of AGBT Pre-Conference Workshop Program Along with Details of Company's Innovative Research Grant Opportunity

GlobeNewswire February 14, 2023

Bionano Strategy Day Highlighted the Company's Strategic Initiatives and Growth Plans as well as OGM's Competitive Value for Cell Bioprocessing, and Cancer and Genetic Disease Research

GlobeNewswire February 9, 2023

Bionano's Symposium 2023 Featured Record Numbers of Presentations Demonstrating Applications of OGM Across Cell Bioprocessing and Constitutional Genetic Disease and Cancer Research

GlobeNewswire February 2, 2023

Bionano Laboratories Expands its Clinical Testing Menu with Launch of its First OGM-Based Laboratory Developed Test (LDT) for Hematological Malignancies

GlobeNewswire January 24, 2023

Bionano Announces Launch of Next-Generation Versions of its Reagent Kits and Chip Consumable, Along with Updates to its Instrument Control and Bionano Access Software for the Optical Genome Mapping Workflow

GlobeNewswire January 23, 2023

Bionano Genomics Announces the Final Speaker Lineup for Symposium 2023 with 30 OGM Presentations and Live Panel Discussions Across a Wide Range of Genetic Disease and Cancer Research Applications

GlobeNewswire January 20, 2023

Bionano Announces Publication of Interim Readout from Clinical Trial Run by Consortium Analyzing Optical Genome Mapping as Potential Standard of Care for Prenatal Testing

GlobeNewswire January 18, 2023

Bionano to Accelerate Data Processing Solution for Optical Genome Mapping Workflow with NVIDIA

GlobeNewswire January 12, 2023

Bionano Announces Publication from Institut Curie Showing Utility of OGM for Detection of HRD in Breast Cancer

GlobeNewswire January 11, 2023

Bionano Genomics Announces 2023 Symposium: Four Consecutive Days of OGM Presentations and Live Panel Discussions Across a Wide Range of Genetic Disease and Cancer Applications

GlobeNewswire January 10, 2023

Bionano Genomics to Host Strategy Day on February 2, 2023 in New York City

GlobeNewswire January 6, 2023

Bionano Genomics Reports Preliminary Fourth Quarter and Full-Year 2022 Results

GlobeNewswire January 5, 2023

Multi-Center Research Study Illustrates How OGM Can Potentially Result in More Patients Qualifying for Treatments in Leukemia

GlobeNewswire December 9, 2022

Bionano Genomics Announces American Society of Hematology (ASH) Annual Meeting Presentations Featuring OGM Utility Across Blood Cancer Research Applications

GlobeNewswire December 8, 2022

Bionano Genomics to Acquire Purigen Biosystems to Enable Further Simplified and Accelerated DNA Isolation for Optical Genome Mapping (OGM) and Address Difficult Sample Types in New Applications with Isotachophoresis (ITP) on the Ionic Purification System

GlobeNewswire November 28, 2022

Publication Shows Utility of OGM in Solid Tumor Research with Study on Detection of Complex Genomic Rearrangements in Prostate Cancer

GlobeNewswire November 21, 2022

Bionano Genomics Appoints Donna Polizio as Its First Ever Global Head of Market Access

GlobeNewswire November 10, 2022

Bionano Genomics Reports Third Quarter 2022 Financial Results and Highlights Recent Business Progress

GlobeNewswire November 3, 2022